Multicenter Diagnostic Evaluation of OnSite COVID-19 Rapid Test (CTK Biotech) among Symptomatic Individuals in Brazil and the United Kingdom

Research output: Contribution to journalArticlepeer-review

Abstract

Evaluating rapid diagnostic tests in diverse populations is essential to improving diagnostic responses as it gives an indication of the accuracy in real-world scenarios. In the case of rapid diagnostic testing within this pandemic, lateral flow tests that meet the minimum requirements for sensitivity and specificity can play a key role in increasing testing capacity, allowing timely clinical management of those infected, and protecting health care systems.

Original languageEnglish
Pages (from-to)e05044-22
JournalMicrobiology spectrum
Volume11
Issue number3
Early online date22 May 2023
DOIs
Publication statusPublished - 22 May 2023

Keywords

  • COVID-19
  • diagnostics
  • RDT

Fingerprint

Dive into the research topics of 'Multicenter Diagnostic Evaluation of OnSite COVID-19 Rapid Test (CTK Biotech) among Symptomatic Individuals in Brazil and the United Kingdom'. Together they form a unique fingerprint.

Cite this